Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Buy
101,148
+6,268
+7% +$724K 1.13% 25
2025
Q4
$9.99M Buy
94,880
+1,631
+2% +$153K 0.98% 27
2025
Q3
$7.83M Buy
93,249
+1,533
+2% +$126K 0.75% 40
2025
Q2
$7.26M Buy
+91,716
New +$7.29M 0.77% 38
2024
Q3
Sell
-5,121
Closed -$634K 197
2024
Q2
$634K Buy
+5,121
New +$660K 0.1% 87
2024
Q1
Sell
-3
Closed -$366 139
2023
Q4
$366 Buy
+3
New +$311 0.08% 94
2021
Q4
Sell
-1,000
Closed -$75K 337
2021
Q3
$75K Buy
+1,000
New +$76.1K 0.01% 244
2020
Q2
Sell
-52,684
Closed -$3.87M 105
2020
Q1
$3.87M Buy
52,684
+3,455
+7% +$272K 1.51% 22
2019
Q4
$4.27M Buy
49,229
+3,699
+8% +$304K 1.31% 24
2019
Q3
$3.66M Buy
45,530
+43,488
+2,130% +$3.49M 1.21% 28
2019
Q2
$163K Buy
+2,042
New +$156K 0.05% 142
2018
Q1
Sell
-6,588
Closed -$356K 109
2017
Q4
$356K Sell
6,588
-27,399
-81% -$1.52M 0.16% 78
2017
Q3
$2.09M Buy
33,987
+285
+0.8% +$17.3K 0.77% 53
2017
Q2
$2.02M Buy
33,702
+7,979
+31% +$486K 0.8% 51
2017
Q1
$1.56M Buy
25,723
+7,360
+40% +$447K 0.96% 43
2016
Q4
$1.1M Buy
18,363
+5,892
+47% +$345K 0.52% 65
2016
Q3
$743K Buy
+12,471
New +$729K 0.41% 80

Other funds holding MRK

IBEX Wealth Advisors's MRK Position: Q1 2026 in Review

IBEX Wealth Advisors increased its Merck (MRK) stake by 6.6% in Q1 2026, buying an estimated $724K and bringing the position to 101,148 shares worth $12.2M. The position accounts for 1.13% of the portfolio, ranked #25.

IBEX Wealth Advisors first reported a position in MRK in Q3 2016 and has held it in 17 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • IBEX Wealth Advisors held 101,148 shares of Merck worth $12.2M as of Q1 2026.
  • IBEX Wealth Advisors bought 6,268 Merck shares in Q1 2026, an estimated $724K.
  • Merck made up 1.13% of IBEX Wealth Advisors's portfolio in Q1 2026, its #25 holding.
  • IBEX Wealth Advisors first reported a position in Merck in Q3 2016 and has held it in 17 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on IBEX Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.